The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10753-019-00989-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds.
J Ovarian Res
April 2024
Department of Biomedical Laboratory Science & Management, Vidyasagar University, Midnapore, West Bengal, India.
Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder in women that necessitates effective and safe treatment alternatives. This study aimed to evaluate the therapeutic efficacy of Vitex negundo seed in a letrozole-induced PCOS rat model.
Results: Findings of the present study demonstrated that administration of hydro-ethanolic extract of Vitex negundo (VNE) effectively restored endocrino-metabolic imbalances associated with PCOS, along with correction of antioxidant enzymes level, proinflammatory cytokines, and apoptotic bio-markers.
Author Correction: Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Acta Pharmacol Sin
April 2020
Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
During re-read of our previously article Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of micepublished in Acta Pharmacologica Sinica, we were regretted to point out a mistake shown in Fig. 2a. The representative figure chosen to indicate the inhibitory effect of 4 mg/kg of plumbagin treatment at 1 week against MDA-MB-231SArfp cells localization within bone environment was incorrect due to the mishandling in manuscript preparation.
View Article and Find Full Text PDFCorrection to: Suppressive effects of plumbagin on invasion and migration of breast cancer cells via the inhibition of STAT3 signaling and down-regulation of inflammatory cytokine expressions.
Bone Res
May 2019
1Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011 China.
[This corrects the article DOI: 10.4248/BR201304007.].
View Article and Find Full Text PDFAuthor Correction: Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid in vitro.
Acta Pharmacol Sin
August 2019
Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
The authors regretted to find the mis-representative images in Fig. 3a, c and Fig. 4a, c when re-read our previously published article Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro (DOI: 10.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!